| |
| |
|
| Insider
Information: |
Bollag Daniel M |
| Relationship: |
See Remarks |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
197,188 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
197,188 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ariad Pharmaceuticals Inc |
ARIA |
Sr. VP, Reg. Affairs &... |
2016-03-21 |
155,088 |
2010-10-26 |
0 |
Premium* |
|
|
Ocular Therapeutix, Inc |
OCUL |
See Remarks |
2018-12-06 |
42,100 |
2017-12-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OCUL |
Ocular Therapeutix, Inc |
See Remarks |
• – – |
2018-12-06 |
4 |
B |
$5.76 |
$100,224 |
D/D |
17,400 |
42,100 |
2.74 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
See Remarks |
• – – |
2017-12-06 |
4 |
B |
$3.93 |
$97,071 |
D/D |
24,700 |
24,700 |
2.74 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• – – |
2016-03-21 |
4 |
AS |
$6.47 |
$25,871 |
D/D |
(4,000) |
155,088 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• – – |
2016-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
159,088 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• – – |
2016-03-15 |
4 |
D |
$6.18 |
$141,009 |
D/D |
(22,814) |
132,024 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• – – |
2016-03-15 |
4 |
OE |
$1.30 |
$4,875 |
D/D |
3,750 |
154,838 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• • – |
2016-03-03 |
4 |
AS |
$6.11 |
$58,852 |
D/D |
(9,625) |
151,088 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• • – |
2016-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,250 |
160,713 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• • – |
2016-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,333 |
156,130 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• • – |
2016-02-01 |
4 |
AS |
$4.81 |
$70,548 |
D/D |
(14,667) |
141,463 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• • – |
2015-09-28 |
4/A |
AS |
$6.46 |
$32,316 |
D/D |
(5,000) |
126,797 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• • – |
2015-09-28 |
4 |
S |
$6.46 |
$32,316 |
D/D |
(5,000) |
126,797 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• • – |
2015-09-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
131,797 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• • – |
2015-07-16 |
4 |
AS |
$8.54 |
$34,164 |
D/D |
(4,000) |
121,797 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• • – |
2015-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
125,797 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• • – |
2015-03-23 |
4 |
AS |
$8.55 |
$25,661 |
D/D |
(3,000) |
117,797 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• • – |
2015-03-20 |
4 |
AS |
$8.85 |
$35,390 |
D/D |
(4,000) |
114,797 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• • – |
2015-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
120,797 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• • – |
2015-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
118,797 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• • – |
2015-03-16 |
4 |
S |
$8.62 |
$296,651 |
D/D |
(34,425) |
110,797 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• • – |
2015-03-16 |
4 |
OE |
$1.30 |
$9,750 |
D/D |
7,500 |
145,222 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• • – |
2015-02-02 |
4 |
AS |
$6.33 |
$92,823 |
D/D |
(14,667) |
137,722 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• • – |
2015-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,334 |
152,389 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• • – |
2014-09-02 |
4 |
AS |
$6.22 |
$352,227 |
D/D |
(56,650) |
123,055 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Sr. VP, Reg. Affairs & Quality |
• • – |
2014-09-02 |
4 |
OE |
$1.30 |
$34,125 |
D/D |
26,250 |
179,705 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
